News
OPCH
33.54
+1.09%
0.36
Is Option Care Health, Inc. (NASDAQ:OPCH) Trading At A 42% Discount?
Option Care Health, Inc. (NASDAQ:OPCH) is projected to be 42% undervalued. The US$39.57 analyst price target for OPCH is 31% less than its fair value. We use a two-stage discounted cash flow model to estimate the future value of the company. The company is estimated to be worth US$57.00 based on the 2 Stage Free Cash Flow to Equity. Option Care Health's current share price of US$33.18 suggests the stock is 42% below its true value.
Simply Wall St · 15h ago
Weekly Report: what happened at OPCH last week (0318-0322)?
Weekly Report · 4d ago
Weekly Report: what happened at OPCH last week (0311-0315)?
Weekly Report · 03/18 09:05
Truist Financial Sticks to Their Buy Rating for Option Care Health (OPCH)
TipRanks · 03/15 11:08
Option Care warns financial impact from UnitedHealth hack
Healthcare Option Care warns financial impact from UnitedHealth hack. Option Care Health says it cannot process more than half of medical claims for services it offers. The company says the hack will affect its near-term financials. UnitedHealth's Change Healthcare unit was hacked in late February.
Seeking Alpha · 03/15 11:05
Option Care Health Insiders Added US$3.22m Of Stock To Their Holdings
Multiple insiders have bought up Option Care Health, Inc. Shares over the last 12 months. The company bought US$1.9m worth of shares at a price of US$34.63 in the last year. In the last three months there was more insider buying than selling at option care health. We think the company's insiders are optimistic about the future of the company. You can see the insider transactions of Option care health, over the years.
Simply Wall St · 03/15 10:55
Option Care Health Navigates Vendor Cybersecurity Disruption
TipRanks · 03/14 20:13
Option Care Health (OPCH) Shares Cross Below 200 DMA
NASDAQ · 03/14 15:45
Weekly Report: what happened at OPCH last week (0304-0308)?
Weekly Report · 03/11 09:05
Tracking 13Fs: Daniel Loeb's Third Point Q4 2023
Daniel Loeb's Third Point's portfolio is still top-heavy, with 10 stocks making up 70% of its AUM. The fund made a large trade by purchasing shares of Verizon and closing out its T-Mobile position. Third Point reduced its positions in Uber, Taiwan Semiconductor, and others.
Seeking Alpha · 03/10 07:56
Option Care Health Price Target Raised to $38.00/Share From $36.00 by Jefferies
Dow Jones · 03/04 14:49
Option Care Health Is Maintained at Buy by Jefferies
Dow Jones · 03/04 14:49
Jefferies Maintains Buy on Option Care Health, Raises Price Target to $38
Benzinga · 03/04 14:39
Weekly Report: what happened at OPCH last week (0226-0301)?
Weekly Report · 03/04 09:05
Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q4 2023 Update
Duquesne Family Office's 13F portfolio value increased from $2.79B to $3.35B in Q4 2023. The largest five stakes in the portfolio are Nvidia, Microsoft, Coupang, Eli Lilly, and Teck Resources. New stakes established during the quarter include Arista Networks, Woodward, and more.
Seeking Alpha · 03/01 04:38
Thursday 2/29 Insider Buying Report: OPCH, NHI
NASDAQ · 02/29 19:36
Truist Financial Keeps Their Buy Rating on Option Care Health (OPCH)
TipRanks · 02/29 12:17
Weekly Report: what happened at OPCH last week (0219-0223)?
Weekly Report · 02/26 09:05
Option Care Health Price Target Raised to $38.00/Share From $35.00 by Barrington Research
Dow Jones · 02/23 14:23
Option Care Health Is Maintained at Outperform by Barrington Research
Dow Jones · 02/23 14:23
More
Webull provides a variety of real-time OPCH stock news. You can receive the latest news about Option Care Health Inc through multiple platforms. This information may help you make smarter investment decisions.
About OPCH
Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 93 full-service pharmacies and 84 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory disorders, immunoglobulin infusion, bleeding disorders infusion, nutrition support infusion, neurological disorders, and others. The Company’s home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.